Rheumatic diseases in pregnancy
Identifieur interne : 001282 ( Istex/Corpus ); précédent : 001281; suivant : 001283Rheumatic diseases in pregnancy
Auteurs : Caroline GordonSource :
- Current Obstetrics & Gynaecology [ 0957-5847 ] ; 1995.
English descriptors
- Teeft :
- Active disease, Active lupus, Ankylosing spondylitis, Anticardiolipin antibodies, Antiphospholipid, Antiphospholipid antibodies, Antiphospholipid antibody syndrome, Antiphospholipid syndrome, Arthritis, Arthritis rheum, Aspirin, Cardiac failure, Clinical rheumatology, Congenital heartblock, Connective tissue, Considerable risk, Contraceptive pill, Current obstetrics, Debatable issue, Disease activity, Disease flare, Dose aspirin, Drug treatment, Early pregnancy, Epidural anaesthesia, Erythematosus, Fetal, Fetal complications, Fetal development, Fetal loss, Fetal outcome, Fetus, First time, Haemolytic anaemia, Hellp syndrome, Hepatic infarction, High levels, High risk, Hypertension, Inflammatory, Inflammatory arthritis, Inflammatory arthropathies, Inflammatory processes, Interuterine growth retardation, Lupus, Lupus anticoagulant, Lupus erythematosus, Lupus flare, Maternal complications, Maternal disease, Neonatal lupus, Neonatal lupus syndrome, Obstet gynecol, Oxford textbook, Oxford university press, Photosensitive rashes, Polyarteritis nodosa, Postpartum flare, Prednisolone, Pregnancy, Pregnant mother, Pregnant patient, Preterm delivery, Pulmonary hypertension, Recurrent miscarriages, Renal, Renal disease, Renal involvement, Rheum, Rheumatic, Rheumatic disease, Rheumatic diseases, Rheumatoid arthritis, Rheumatology, Skin rashes, Spondylitis, Spontaneous abortion, Steroid, Steroid therapy, Syndrome, Systemic, Systemic disease, Systemic lupus erythematosus, Systemic sclerosis, Third trimester, Vasculitis.
Abstract
Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.
Url:
DOI: 10.1016/S0957-5847(09)80009-7
Links to Exploration step
ISTEX:C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rheumatic diseases in pregnancy</title><author><name sortKey="Gordon, Caroline" sort="Gordon, Caroline" uniqKey="Gordon C" first="Caroline" last="Gordon">Caroline Gordon</name><affiliation><mods:affiliation>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8B</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1016/S0957-5847(09)80009-7</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001282</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001282</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rheumatic diseases in pregnancy</title><author><name sortKey="Gordon, Caroline" sort="Gordon, Caroline" uniqKey="Gordon C" first="Caroline" last="Gordon">Caroline Gordon</name><affiliation><mods:affiliation>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Current Obstetrics & Gynaecology</title><title level="j" type="abbrev">YCUOG</title><idno type="ISSN">0957-5847</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995">1995</date><biblScope unit="volume">5</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="163">163</biblScope><biblScope unit="page" to="168">168</biblScope></imprint><idno type="ISSN">0957-5847</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0957-5847</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Active disease</term><term>Active lupus</term><term>Ankylosing spondylitis</term><term>Anticardiolipin antibodies</term><term>Antiphospholipid</term><term>Antiphospholipid antibodies</term><term>Antiphospholipid antibody syndrome</term><term>Antiphospholipid syndrome</term><term>Arthritis</term><term>Arthritis rheum</term><term>Aspirin</term><term>Cardiac failure</term><term>Clinical rheumatology</term><term>Congenital heartblock</term><term>Connective tissue</term><term>Considerable risk</term><term>Contraceptive pill</term><term>Current obstetrics</term><term>Debatable issue</term><term>Disease activity</term><term>Disease flare</term><term>Dose aspirin</term><term>Drug treatment</term><term>Early pregnancy</term><term>Epidural anaesthesia</term><term>Erythematosus</term><term>Fetal</term><term>Fetal complications</term><term>Fetal development</term><term>Fetal loss</term><term>Fetal outcome</term><term>Fetus</term><term>First time</term><term>Haemolytic anaemia</term><term>Hellp syndrome</term><term>Hepatic infarction</term><term>High levels</term><term>High risk</term><term>Hypertension</term><term>Inflammatory</term><term>Inflammatory arthritis</term><term>Inflammatory arthropathies</term><term>Inflammatory processes</term><term>Interuterine growth retardation</term><term>Lupus</term><term>Lupus anticoagulant</term><term>Lupus erythematosus</term><term>Lupus flare</term><term>Maternal complications</term><term>Maternal disease</term><term>Neonatal lupus</term><term>Neonatal lupus syndrome</term><term>Obstet gynecol</term><term>Oxford textbook</term><term>Oxford university press</term><term>Photosensitive rashes</term><term>Polyarteritis nodosa</term><term>Postpartum flare</term><term>Prednisolone</term><term>Pregnancy</term><term>Pregnant mother</term><term>Pregnant patient</term><term>Preterm delivery</term><term>Pulmonary hypertension</term><term>Recurrent miscarriages</term><term>Renal</term><term>Renal disease</term><term>Renal involvement</term><term>Rheum</term><term>Rheumatic</term><term>Rheumatic disease</term><term>Rheumatic diseases</term><term>Rheumatoid arthritis</term><term>Rheumatology</term><term>Skin rashes</term><term>Spondylitis</term><term>Spontaneous abortion</term><term>Steroid</term><term>Steroid therapy</term><term>Syndrome</term><term>Systemic</term><term>Systemic disease</term><term>Systemic lupus erythematosus</term><term>Systemic sclerosis</term><term>Third trimester</term><term>Vasculitis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.</div></front></TEI><istex><corpusName>elsevier</corpusName><keywords><teeft><json:string>lupus</json:string><json:string>antiphospholipid</json:string><json:string>fetal</json:string><json:string>antiphospholipid antibodies</json:string><json:string>fetus</json:string><json:string>pregnancy</json:string><json:string>fetal loss</json:string><json:string>hypertension</json:string><json:string>vasculitis</json:string><json:string>rheumatology</json:string><json:string>spondylitis</json:string><json:string>prednisolone</json:string><json:string>erythematosus</json:string><json:string>arthritis rheum</json:string><json:string>rheumatic diseases</json:string><json:string>antiphospholipid syndrome</json:string><json:string>first time</json:string><json:string>systemic disease</json:string><json:string>clinical rheumatology</json:string><json:string>rheumatoid arthritis</json:string><json:string>lupus anticoagulant</json:string><json:string>systemic lupus erythematosus</json:string><json:string>rheum</json:string><json:string>arthritis</json:string><json:string>inflammatory</json:string><json:string>ankylosing spondylitis</json:string><json:string>third trimester</json:string><json:string>systemic sclerosis</json:string><json:string>renal involvement</json:string><json:string>dose aspirin</json:string><json:string>rheumatic disease</json:string><json:string>renal</json:string><json:string>syndrome</json:string><json:string>steroid</json:string><json:string>obstet gynecol</json:string><json:string>congenital heartblock</json:string><json:string>drug treatment</json:string><json:string>fetal development</json:string><json:string>anticardiolipin antibodies</json:string><json:string>hepatic infarction</json:string><json:string>disease activity</json:string><json:string>active disease</json:string><json:string>pulmonary hypertension</json:string><json:string>neonatal lupus</json:string><json:string>fetal outcome</json:string><json:string>cardiac failure</json:string><json:string>systemic</json:string><json:string>rheumatic</json:string><json:string>aspirin</json:string><json:string>inflammatory processes</json:string><json:string>active lupus</json:string><json:string>renal disease</json:string><json:string>photosensitive rashes</json:string><json:string>recurrent miscarriages</json:string><json:string>lupus erythematosus</json:string><json:string>epidural anaesthesia</json:string><json:string>preterm delivery</json:string><json:string>skin rashes</json:string><json:string>steroid therapy</json:string><json:string>high risk</json:string><json:string>maternal complications</json:string><json:string>spontaneous abortion</json:string><json:string>antiphospholipid antibody syndrome</json:string><json:string>current obstetrics</json:string><json:string>high levels</json:string><json:string>contraceptive pill</json:string><json:string>lupus flare</json:string><json:string>postpartum flare</json:string><json:string>considerable risk</json:string><json:string>pregnant mother</json:string><json:string>interuterine growth retardation</json:string><json:string>polyarteritis nodosa</json:string><json:string>disease flare</json:string><json:string>connective tissue</json:string><json:string>maternal disease</json:string><json:string>early pregnancy</json:string><json:string>pregnant patient</json:string><json:string>inflammatory arthropathies</json:string><json:string>debatable issue</json:string><json:string>neonatal lupus syndrome</json:string><json:string>hellp syndrome</json:string><json:string>fetal complications</json:string><json:string>inflammatory arthritis</json:string><json:string>oxford textbook</json:string><json:string>oxford university press</json:string><json:string>haemolytic anaemia</json:string></teeft></keywords><author><json:item><name>Caroline Gordon</name><affiliations><json:string>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Obstetrics</value></json:item></subject><articleId><json:string>80009</json:string></articleId><arkIstex>ark:/67375/6H6-0338XQ81-8</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>Full-length article</json:string></originalGenre><abstract>Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.</abstract><qualityIndicators><score>7.706</score><pdfWordCount>4038</pdfWordCount><pdfCharCount>26873</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>6</pdfPageCount><pdfPageSize>576 x 864 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractWordCount>139</abstractWordCount><abstractCharCount>946</abstractCharCount><keywordCount>1</keywordCount></qualityIndicators><title>Rheumatic diseases in pregnancy</title><pii><json:string>S0957-5847(09)80009-7</json:string></pii><genre><json:string>research-article</json:string></genre><host><title>Current Obstetrics & Gynaecology</title><language><json:string>unknown</json:string></language><publicationDate>1995</publicationDate><issn><json:string>0957-5847</json:string></issn><pii><json:string>S0957-5847(05)X8015-5</json:string></pii><volume>5</volume><issue>3</issue><pages><first>163</first><last>168</last></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>2000</json:string><json:string>1995</json:string><json:string>7500</json:string></date><geogName></geogName><orgName></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Recent</json:string></persName><placeName></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/6H6-0338XQ81-8</json:string></ark><categories><wos></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - obstetrics & reproductive medicine</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Obstetrics and Gynaecology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>1995</publicationDate><copyrightDate>1995</copyrightDate><doi><json:string>10.1016/S0957-5847(09)80009-7</json:string></doi><id>C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8B</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Rheumatic diseases in pregnancy</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher><availability><licence><p>©1995 Pearson Professional Ltd All rights reserved</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</p></availability><date>1995</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Rheumatic diseases in pregnancy</title><author xml:id="author-0000"><persName><forename type="first">Caroline</forename><surname>Gordon</surname></persName><affiliation>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</affiliation></author><idno type="istex">C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8B</idno><idno type="ark">ark:/67375/6H6-0338XQ81-8</idno><idno type="DOI">10.1016/S0957-5847(09)80009-7</idno><idno type="PII">S0957-5847(09)80009-7</idno><idno type="article-id">80009</idno></analytic><monogr><title level="j">Current Obstetrics & Gynaecology</title><title level="j" type="abbrev">YCUOG</title><idno type="pISSN">0957-5847</idno><idno type="PII">S0957-5847(05)X8015-5</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1995"></date><biblScope unit="volume">5</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="163">163</biblScope><biblScope unit="page" to="168">168</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1995</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.</p></abstract><textClass><keywords scheme="keyword"><list><head>article-category</head><item><term>Obstetrics</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier doc found" wicri:toSee="Elsevier, no converted or simple article"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 5.0.1//EN//XML" URI="art501.dtd" name="istex:docType"></istex:docType><istex:document><article version="5.0" xml:lang="en" docsubtype="fla"><item-info><jid>YCUOG</jid><aid>80009</aid><ce:pii>S0957-5847(09)80009-7</ce:pii><ce:doi>10.1016/S0957-5847(09)80009-7</ce:doi><ce:copyright type="unknown" year="1995">Pearson Professional Ltd All rights reserved</ce:copyright><ce:doctopics><ce:doctopic><ce:text>Obstetrics</ce:text></ce:doctopic></ce:doctopics></item-info><head><ce:title>Rheumatic diseases in pregnancy</ce:title><ce:author-group><ce:author><ce:given-name>Caroline</ce:given-name><ce:surname>Gordon</ce:surname></ce:author><ce:affiliation id="aff1"><ce:textfn>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</ce:textfn></ce:affiliation></ce:author-group><ce:abstract id="ab1" class="author" xml:lang="en"><ce:abstract-sec><ce:simple-para>Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.</ce:simple-para></ce:abstract-sec></ce:abstract></head><tail><ce:bibliography><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>1.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Silman</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Kay</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Brennan</ce:surname><ce:given-name>P</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Timing of pregnancy in relation to the onset of rheumatoid arthritis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>152</sb:first-page><sb:last-page>155</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>2.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Da Silva</ce:surname><ce:given-name>JAP</ce:given-name></sb:author><sb:author><ce:surname>Hall</ce:surname><ce:given-name>GM</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>The effects of gender and sex hormones on outcome in rheumatoid arthritis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bailliere's Clinical Rheumatology</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>193</sb:first-page><sb:last-page>219</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>3.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Spector</ce:surname><ce:given-name>TD</ce:given-name></sb:author><sb:author><ce:surname>Roman</ce:surname><ce:given-name>E</ce:given-name></sb:author><sb:author><ce:surname>Silman</ce:surname><ce:given-name>AJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>The pill, parity, and rheumatoid arthritis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>33</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>782</sb:first-page><sb:last-page>789</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>4.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Buchanan</ce:surname><ce:given-name>WW</ce:given-name></sb:author><sb:author><ce:surname>Kean</ce:surname><ce:given-name>WF</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Pregnancy and the rheumatic diseases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Maddison</ce:surname><ce:given-name>PJ</ce:given-name></sb:editor><sb:editor><ce:surname>Isenberg</ce:surname><ce:given-name>DA</ce:given-name></sb:editor><sb:editor><ce:surname>Woo</ce:surname><ce:given-name>P</ce:given-name></sb:editor><sb:editor><ce:surname>Glass</ce:surname><ce:given-name>DN</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Oxford Textbook of Rheumatology</sb:maintitle></sb:title><sb:date>1993</sb:date><sb:publisher><sb:name>Oxford University Press</sb:name><sb:location>Oxford</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>93</sb:first-page><sb:last-page>98</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>5.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ostensen</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Husby</ce:surname><ce:given-name>G</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>1983</sb:date></sb:issue><sb:pages><sb:first-page>1155</sb:first-page><sb:last-page>1159</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>6.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Kean</ce:surname><ce:given-name>WF</ce:given-name></sb:author><sb:author><ce:surname>Buchanan</ce:surname><ce:given-name>WW</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Pregnancy and rheumatic disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bailliere's Clinical Rheumatology</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>125</sb:first-page><sb:last-page>140</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>7.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Buyon</ce:surname><ce:given-name>JP</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Systemic lupus erythematosus and the maternalfetal dyad</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bailliere's Clinical Rheumatology</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>85</sb:first-page><sb:last-page>103</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>8.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Petri</ce:surname><ce:given-name>M</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Systemic lupus erythematosus and pregnancy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Rheum Dis Clin North Am</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>87</sb:first-page><sb:last-page>118</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>9.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Urowitz</ce:surname><ce:given-name>MB</ce:given-name></sb:author><sb:author><ce:surname>Gladman</ce:surname><ce:given-name>DD</ce:given-name></sb:author><sb:author><ce:surname>Farewell</ce:surname><ce:given-name>VT</ce:given-name></sb:author><sb:author><ce:surname>Stewart</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>McDonald</ce:surname><ce:given-name>J</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Lupus and pregnancy studies</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>36</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>1392</sb:first-page><sb:last-page>1397</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>10.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Buyon</ce:surname><ce:given-name>JP</ce:given-name></sb:author><sb:author><ce:surname>Tamerius</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>Ordorica</ce:surname><ce:given-name>S</ce:given-name></sb:author><sb:author><ce:surname>Young</ce:surname><ce:given-name>B</ce:given-name></sb:author><sb:author><ce:surname>Abramson</ce:surname><ce:given-name>SB</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Activation of alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>35</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>55</sb:first-page><sb:last-page>61</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>11.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Petri</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Allbritton</ce:surname><ce:given-name>J</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Rheumatol</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>650</sb:first-page><sb:last-page>656</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>12.</ce:label><ce:other-ref><ce:textref>Petri M. Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am; 20: 443–69</ce:textref></ce:other-ref></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>13.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Ehrenfeld</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Schoenfeld</ce:surname><ce:given-name>Y</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Haematology and oncology in rheumatology</sb:maintitle></sb:title></sb:contribution><sb:host><sb:edited-book><sb:editors><sb:editor><ce:surname>Maddison</ce:surname><ce:given-name>PJ</ce:given-name></sb:editor><sb:editor><ce:surname>Isenberg</ce:surname><ce:given-name>DA</ce:given-name></sb:editor><sb:editor><ce:surname>Woo</ce:surname><ce:given-name>P</ce:given-name></sb:editor><sb:editor><ce:surname>Glass</ce:surname><ce:given-name>DN</ce:given-name></sb:editor></sb:editors><sb:title><sb:maintitle>Oxford Textbook of Rheumatology</sb:maintitle></sb:title><sb:date>1993</sb:date><sb:publisher><sb:name>Oxford University Press</sb:name><sb:location>Oxford</sb:location></sb:publisher></sb:edited-book><sb:pages><sb:first-page>154</sb:first-page><sb:last-page>162</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>14.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Lynch</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Marlar</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Murphy</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>Davila</ce:surname><ce:given-name>G</ce:given-name></sb:author><sb:author><ce:surname>Santos</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Rutledge</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>Emlen</ce:surname><ce:given-name>W</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann Intern Med</sb:maintitle></sb:title><sb:volume-nr>120</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>470</sb:first-page><sb:last-page>475</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>15.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Mor</ce:surname><ce:given-name>F</ce:given-name></sb:author><sb:author><ce:surname>Beigel</ce:surname><ce:given-name>Y</ce:given-name></sb:author><sb:author><ce:surname>Inbal</ce:surname><ce:given-name>A</ce:given-name></sb:author><sb:author><ce:surname>Goren</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Wysenbeek</ce:surname><ce:given-name>AJ</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Hepatic infarction in a patient with lupus anticoagulant</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>491</sb:first-page><sb:last-page>495</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>16.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Kilpatrick</ce:surname><ce:given-name>DC</ce:given-name></sb:author><sb:author><ce:surname>Maclean</ce:surname><ce:given-name>C</ce:given-name></sb:author><sb:author><ce:surname>Liston</ce:surname><ce:given-name>QA</ce:given-name></sb:author><sb:author><ce:surname>Johnstone</ce:surname><ce:given-name>FD</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Antiphospholipid antibody syndrome and pre-eclampsia</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Lancet</sb:maintitle></sb:title><sb:volume-nr>ii</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>987</sb:first-page><sb:last-page>988</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>17.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Kinoshita</ce:surname><ce:given-name>K</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Hepatic infarction during pregnancy complicated by antiphospholipid syndrome</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Obstet Gynecol</sb:maintitle></sb:title><sb:volume-nr>169</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>199</sb:first-page><sb:last-page>202</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>18.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Dudley</ce:surname><ce:given-name>DJ</ce:given-name></sb:author><sb:author><ce:surname>Branch</ce:surname><ce:given-name>DW</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Pregnancy in the patient with rheumatic disease: the obstetrician's perspective</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bailliere's Clinical Rheumatology</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>141</sb:first-page><sb:last-page>156</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>19.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Black</ce:surname><ce:given-name>CM</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Systemic sclerosis and pregnancy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bailliere's Clinical Rheumatology</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>105</sb:first-page><sb:last-page>121</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>20.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Friedman</ce:surname><ce:given-name>SA</ce:given-name></sb:author><sb:author><ce:surname>Bernstein</ce:surname><ce:given-name>MS</ce:given-name></sb:author><sb:author><ce:surname>Kitzmiller</ce:surname><ce:given-name>JL</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Pregnancy complicated by collagen vascular disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Obstet Gynecol Clin North Am</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>213</sb:first-page><sb:last-page>236</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>21.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Pauzner</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Mayan</ce:surname><ce:given-name>H</ce:given-name></sb:author><sb:author><ce:surname>Hershko</ce:surname><ce:given-name>E</ce:given-name></sb:author><sb:author><ce:surname>Alcalay</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Farfel</ce:surname><ce:given-name>Z</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Exacerbation of Wegener's granulomatosis during pregnancy: report of a case with tracheal stenosis and literature review</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Rheumatol</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>1153</sb:first-page><sb:last-page>1156</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>22.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Roubenoff</ce:surname><ce:given-name>R</ce:given-name></sb:author><sb:author><ce:surname>Hoyt</ce:surname><ce:given-name>J</ce:given-name></sb:author><sb:author><ce:surname>Petri</ce:surname><ce:given-name>M</ce:given-name></sb:author><sb:author><ce:surname>Hellmann</ce:surname><ce:given-name>DB</ce:given-name></sb:author><sb:author><ce:surname>Hochberg</ce:surname><ce:given-name>MC</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Semin Arthritis Rheum</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>88</sb:first-page><sb:last-page>110</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>23.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Lockshin</ce:surname><ce:given-name>MD</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Which patients with antiphospholipid antibody should be treated and how?</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Rheum Dis Clin North Am</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>235</sb:first-page><sb:last-page>247</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>24.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Cowchock</ce:surname><ce:given-name>FS</ce:given-name></sb:author><sb:author><ce:surname>Reece</ce:surname><ce:given-name>EA</ce:given-name></sb:author><sb:author><ce:surname>Balaban</ce:surname><ce:given-name>D</ce:given-name></sb:author><sb:author><ce:surname>Branch</ce:surname><ce:given-name>DW</ce:given-name></sb:author><sb:author><ce:surname>Plouffe</ce:surname><ce:given-name>L</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Obstet Gynecol</sb:maintitle></sb:title><sb:volume-nr>166</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>1318</sb:first-page><sb:last-page>1323</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>25.</ce:label><sb:reference><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>Silver</ce:surname><ce:given-name>RK</ce:given-name></sb:author><sb:author><ce:surname>MacGregor</ce:surname><ce:given-name>SN</ce:given-name></sb:author><sb:author><ce:surname>Sholl</ce:surname><ce:given-name>JS</ce:given-name></sb:author><sb:author><ce:surname>Hobart</ce:surname><ce:given-name>JM</ce:given-name></sb:author><sb:author><ce:surname>Neerhof</ce:surname><ce:given-name>MG</ce:given-name></sb:author><sb:author><ce:surname>Ragin</ce:surname><ce:given-name>A</ce:given-name></sb:author></sb:authors><sb:title><sb:maintitle>Comparative trial of prednisolone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Obstet Gynecol</sb:maintitle></sb:title><sb:volume-nr>169</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>1411</sb:first-page><sb:last-page>1417</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Rheumatic diseases in pregnancy</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Rheumatic diseases in pregnancy</title></titleInfo><name type="personal"><namePart type="given">Caroline</namePart><namePart type="family">Gordon</namePart><affiliation>Department of Rheumatology, University of Birmingham, Birmingham B15 2TT, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1995</dateIssued><copyrightDate encoding="w3cdtf">1995</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Rheumatic diseases often present in women of childbearing age. Fortunately, most forms of inflammatory arthritis improve in pregnancy and maternal or fetal complications are rare. Drug therapy may need to be modified as most drugs cross the placenta but only a few are definitely teratogenic. Ankylosing spondylitis may not remit in pregnancy and can be difficult to manage as the high dose non-steroidal anti-inflammatory drugs usually taken by the patient must be discontinued. Providing that systemic lupus erythematosus is well-controlled at the onset of pregnancy, the prognosis for mother and baby is good. Neonatal lupus syndrome is uncommon. The outcome in the rarer systemic conditions such as scleroderma and vasculitis is less predictable and the risk of serious deterioration in the mother is greater. Close liaison between obstetricians and rheumatologists will ensure optimal management of these potentially complicated pregnancies.</abstract><subject><genre>article-category</genre><topic>Obstetrics</topic></subject><relatedItem type="host"><titleInfo><title>Current Obstetrics & Gynaecology</title></titleInfo><titleInfo type="abbreviated"><title>YCUOG</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1995</dateIssued></originInfo><identifier type="ISSN">0957-5847</identifier><identifier type="PII">S0957-5847(05)X8015-5</identifier><part><date>1995</date><detail type="volume"><number>5</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue-pages"><start>125</start><end>183</end></extent><extent unit="pages"><start>163</start><end>168</end></extent></part></relatedItem><identifier type="istex">C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8B</identifier><identifier type="ark">ark:/67375/6H6-0338XQ81-8</identifier><identifier type="DOI">10.1016/S0957-5847(09)80009-7</identifier><identifier type="PII">S0957-5847(09)80009-7</identifier><identifier type="ArticleID">80009</identifier><accessCondition type="use and reproduction" contentType="copyright">©1995 Pearson Professional Ltd All rights reserved</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource><recordOrigin>Pearson Professional Ltd All rights reserved, ©1995</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/6H6-0338XQ81-8/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001282 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001282 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:C8CD5B414D6F7F50DB7EC2606988E0CFDE067B8B
|texte= Rheumatic diseases in pregnancy
}}
| This area was generated with Dilib version V0.6.33. |  |